$0.4
+0.02
(+5.26%)▲
Live
5.55%
Downside
Day's Volatility :7.85%
Upside
2.44%
40.63%
Downside
52 Weeks Volatility :89.89%
Upside
82.98%
Period | Aethlon Medical Inc | Index (Russel 2000) |
---|---|---|
3 Months | -7.68% | 0.0% |
6 Months | -74.32% | 0.0% |
1 Year | -73.6% | 0.0% |
3 Years | -98.94% | -23.0% |
Market Capitalization | 5.3M |
Book Value | $0.63 |
Earnings Per Share (EPS) | -3.85 |
PEG Ratio | 0.0 |
Wall Street Target Price | 3.86 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -50.46% |
Return On Equity TTM | -105.38% |
Revenue TTM | 574.2K |
Revenue Per Share TTM | 0.24 |
Quarterly Revenue Growth YOY | 4278.2% |
Gross Profit TTM | 574.2K |
EBITDA | -10.6M |
Diluted Eps TTM | -3.85 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -5.43 |
EPS Estimate Next Year | -3.51 |
EPS Estimate Current Quarter | -0.31 |
EPS Estimate Next Quarter | -0.2 |
What analysts predicted
Upside of 865.0%
Sell
Neutral
Buy
Aethlon Medical Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Aethlon Medical Inc | -9.5% | -74.32% | -73.6% | -98.94% | -99.17% |
Stryker Corporation | 0.83% | 12.78% | 40.21% | 33.69% | 71.83% |
Boston Scientific Corp. | 4.85% | 29.48% | 75.68% | 96.28% | 127.87% |
Edwards Lifesciences Corp. | 4.32% | -19.19% | 1.77% | -39.29% | -7.22% |
Abbott Laboratories | 3.99% | 11.51% | 24.65% | -4.53% | 46.22% |
Medtronic Plc | 2.65% | 14.48% | 27.42% | -24.18% | -13.49% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Aethlon Medical Inc | NA | NA | 0.0 | -5.43 | -1.05 | -0.5 | NA | 0.63 |
Stryker Corporation | 40.15 | 40.15 | 2.64 | 12.01 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 70.26 | 70.26 | 2.14 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 27.67 | 27.67 | 3.65 | 2.6 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 35.83 | 35.83 | 4.31 | 4.67 | 0.14 | 0.06 | 0.02 | 22.26 |
Medtronic Plc | 30.23 | 30.23 | 1.67 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Aethlon Medical Inc | Buy | $5.3M | -99.17% | NA | 0.0% |
Stryker Corporation | Buy | $137.1B | 71.83% | 40.15 | 16.12% |
Boston Scientific Corp. | Buy | $127.3B | 127.87% | 70.26 | 12.0% |
Edwards Lifesciences Corp. | Buy | $42.3B | -7.22% | 27.67 | 23.74% |
Abbott Laboratories | Buy | $205.1B | 46.22% | 35.83 | 13.65% |
Medtronic Plc | Buy | $115.2B | -13.49% | 30.23 | 12.06% |
Insights on Aethlon Medical Inc
In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 151.2%
In the last 3 years, Boston Scientific Corp. has given 96.3% return, outperforming this stock by 195.2%
Susquehanna International Group, LLP
TWO SIGMA SECURITIES, LLC
JANE STREET GROUP, LLC
Vanguard Group Inc
Geode Capital Management, LLC
Baader Bank INC
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Organization | Aethlon Medical Inc |
Employees | 14 |
CEO | Mr. James B. Frakes M.B.A. |
Industry | Health Technology |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$0.40
+5.26%
Invesco Bulletshares 2025 Hi
$0.40
+5.26%
Schwab International Dividend Equity Etf
$0.40
+5.26%
Blockchain Coinvestors Acquisition Corp.
$0.40
+5.26%
Allgiant Travel Company
$0.40
+5.26%
Rogers Corp
$0.40
+5.26%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$0.40
+5.26%
Iheartmedia
$0.40
+5.26%
Lightpath Technologies Inc
$0.40
+5.26%